Release Date: 17/08/09 09:36 Summary: $10 million Finance Facility Secured Price Sensitive: Yes Download Document 26.25KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%